48E5E315-9EBA-8CD8-E28A-A7E904CDAD4F	55B7D612-46BA-901D-9367-A7E904CD860E.04215A11-F5BD-654F-DA9A-A7EB049FF103	55B7D612-46BA-901D-9367-A7E904CD860E.EE982CB1-5942-4FE4-713E-A7EF1C2DEDE0	04A8AE8B-F51A-02F9-7E8D-A7E904CDD8CE	5E8556EC-92B9-3AA2-BAA9-A7E904CD4FD7	EB6F0172-0BF8-943E-3966-A7E904CD1832cell-type	reagent-treatment: reagent	reagent-treatment: duration	immunoprecipitate	primary-antibody	mobility-shiftmouse embryo fibroblast	PDGF	"0,1,3,4,10,15"	control	PDGFR	0mouse wmbryo fibroblast	PDGF / control	"0,1,3,4,10,15"	control	Sos-1	1mouse wmbryo fibroblast	PDGF / control	"0,1,3,4,10,15"	PDGFR	PDGFR	0mouse wmbryo fibroblast	PDGF / control	"0,1,3,4,10,15"	PDGFR	Sos-1	0